BioCap comprised a three-day programme, opening on 23rd September with a digital pitching competition. Firstly, congratulations to all who were invited to pitch as the judges had an incredibly tough job cutting a bumper number of entries down to the 12 shortlisted companies presented to a panel of online investors. The following day, the investor mixer provided opportunities for networking, before the main conference took place on 25th September, bringing together 164 exhibitors, speakers, and investors.
On the day, the sessions covered a range of topics, with insights from two life sciences investment outlook panel sessions, company journeys, investor insights, what makes a company scalable, reverse pitching, grants and mixed funding, and of course, the announcement of the three pitching competition finalists and the overall winner.
Read the full event summary here
BioCap 2025 is sponsored by Mills & Reeve, Appleyard Lees, STFC, RSM UK, Bruntwood SciTech, Kadans Science Partner, Pharmora and Withers & Rogers.
Agenda highlights:
Investor Insights
- Tim Davis, Regional Head, UK Primary Markets, London Stock Exchange
- Imelda Juniarsih, Lead Investment Director, Pioneer Group
- Tanya Moore, Investment Principal - Ventures, Cancer Research Horizons
Company Journeys
- Eddy Littler, Chairman, Domainex and MetalloBio in conversation with Graham Bond, Partner, Co-Head of Life Sciences, RSM
- Simon Bryson, CEO & Founder, Proveca
State of the Nation Panel – Life Sciences Investment Outlook - Part One – Investors View
Chair: Graham Bond, Partner, Co-Head of Life Sciences, RSM
Speakers
- Mark Rahn, Partner, Toki Ventures
- Alessio D’addabbo, Analyst, Syncona
- Gordon Bateman, Founder, Climb
- Andy Round, Investment Director, Deepbridge Capital
State of the Nation Panel – Life Sciences Investment Outlook - Part Two – CEO View
Chair: Rachel Mercer, Senior Associate, Appleyard Lees
Speakers
- Joe Hedley, CEO & Co-Founder, NunaBio
- Tiffany Thorn, CEO & Founder, BiVictriX Therapeutics
- Paul Stott, CEO, Seda PDS
- Gray Kueberuwa, CEO, ImmunoKey
- Rania Maklad, CEO and Co-Founder, OCUWELL
From Lab to Exit: What Makes a Company Scalable
Chair: Bevan McWilliam, Business Development Director, Kadans
Speakers
- Johnny Habchi, Head of R&D Consulting, Medicines Discovery Catapult
- Duncan Henderson, Head of Innovation Discovery, University of Manchester Innovation Factory
- Matt Tate, Managing Director, Gentronix
- Johnathan Matlock, Co-Founder, Empirical Ventures
Reverse Pitching
Speakers
- Alison Maughan, Investment Manager, Northern Gritstone
- Sim Singh Landa, Investment Director, Praetura Ventures
- Farid Khan, Life Sciences Lead, Salonica Infinity Fund
- Doug Quinn, Partner, DSW
Pitching Competition Results
Grants and Mixed Funding
Chair: James Fry, Partner, Head of Life Sciences, Mills and Reeve
Speakers
- Marc Daigneault, Venture Building Lead, Medicines Discovery Catapult
- Jo Derbyshire, Director of Growth Funding, Inventya
- Lorna Green, CEO, LYVA Labs
- Mike Birch, COO, F2G
